Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

February 15, 2024

SWISSPR 2024

SWISSPR 2024 was a great success! Hosted by the Corn, Platt, Schwank and Jinek labs, we had a blast diving into the latest CRISPR research at the beautiful Seminarhotel...

February 2, 2024

Welcome to Benedetta

Benedetta Bellinazzi received her MSc degree in Medical Biotechnology from San Raffaele University (Milan, Italy) in 2023. Benedetta joined the Corn Lab...

October 31, 2023

Welcome to Dominic!

Dominic Mailänder received his Bachelor’s degree in Biology from ETH Zürich in 2022. He is currently enrolled in the Molecular Health Sciences Master’s...

News Archive

Tweets